CAR-T Cellular Therapy: Advancing Pediatric Cancer Treatment with Terry Fry, MD and Michael Verneris, MD S3:E62

Cellular therapy is a new type of immunotherapy that is bringing hope to pediatric patients with blood cancers.  The therapy is more specifically known as chimeric antigen receptor T cell therapy (or CAR-T cell therapy), and it has been hailed as a breakthrough in the field of immunotherapy. CAR-T cell therapy "takes the brakes" off the immune system's response. Essentially, it trains the cells within the immune system, called T cells, to see tumors they weren't naturally developed to recognize. Two years ago, we had the brilliant team of Terry Fry, MD and Mike Verneris, MD join us to discuss this therapy for patients with leukemia and other cancers; you can go back and listen to that initial discussion on Season 1, episode 33. We continue to hear from listeners how much they enjoyed this discussion of clinical invocation and application and decided that it was time to bring Dr. Fry and Dr. Verneris back to hear an update on their work and what the latest in the space of CAR-T cell therapy is.